Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories intangible Assets Amortization Expense ($M) ($M)
Form 8-K Non-GAAP Tables & Form 10-K/10-Q Intangibles Footnote
Latest, Q3 2026
841
Period ended Sep 30, 2026
Change on a year earlier
+100.2%
420 in Q3 2025
History
55 quarters
Since Q1 2013
Sources
46
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up intangible assets amortization expense ($m)
- Forecasted Annual Intangible Amortization — Year 1 ($M)2,300 · Q2 2026
- Forecasted Annual Intangible Amortization — Year 2 ($M)1,800 · Q2 2026
- Forecasted Annual Intangible Amortization — Year 3 ($M)1,700 · Q2 2026
- Forecasted Annual Intangible Amortization — Year 4 ($M)1,500 · Q2 2026
- Forecasted Annual Intangible Amortization — Year 5 ($M)363 · Q4 2025
Cite this data
StockData. (2026). Abbott Laboratories Intangible Assets Amortization Expense ($M) ($M), quarterly Q1 2013–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/gaap-intang-amort
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.